Abstract
Background Of the three opioid receptors, μ (MOP), δ (DOP) and (KOP), the MOP type is the most involved in the action of opioids in the gut. Experimental studies on models of intestinal inflammation and inflammatory bowel disease (IBD) support an anti-inflammatory role of peripheral MOP receptors in the gut, besides their involvement in pain control (analgesia) and gastrointestinal motility (anti-diarrheal effects). Research focuses increasingly on exploring the therapeutic potential of peripheral MOP receptors aiming for identification of peripheral ligands as improved treatment for debilitating conditions associated with bowel functions. One strategy to increase peripheral selectivity includes chemical modifications that enhance hydrophilicity [1,2]. Our work in the field of peripherally acting opioids has led to a series of opioids with zwitterionic moieties (i.e. amino acid residues) attached to the C-6 position of 14-O-methyloxymorphone, which may represent novel therapeutic molecules for IBD. These 14-alkoxymorphinans were pharmacologically and immunologically characterized.
Highlights
Of the three opioid receptors, μ (MOP), δ (DOP) and (KOP), the MOP type is the most involved in the action of opioids in the gut
Synthesis of novel zwitterionic 14-alkoxymorphinans was accomplished by multi-step syntheses
Based on the calculated logP and logD values, an increase of hydrophilicity, and peripheral selectivity can be achieved by attachment of amino acid residues to the morphinan skeleton
Summary
Of the three opioid receptors, μ (MOP), δ (DOP) and (KOP), the MOP type is the most involved in the action of opioids in the gut. Methods Synthesis of novel zwitterionic 14-alkoxymorphinans was accomplished by multi-step syntheses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.